ViralLoop

Today we announced that the U.S. Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research (CBER) has notified Moderna that it will not initiate a review of the biologics license application (BLA) for our investigational influenza vaccine, mRNA-1010, and

533 likes0 repliesPosted Feb 10, 2026

Remix this post

Your note

Private to you, and used when you remix this post.

Viral score

Based on absolute engagement — the platform doesn’t expose follower counts here, so large accounts score higher.

From likes, comments.

Why it worked

Opens with a short, self-contained line that is easy to take in at a glance.
The opening line stands alone, so it reads completely before the post is expanded.
Written from experience rather than as advice, which is harder to argue with.
Short enough to read in full without expanding, which removes a step before the point lands.

The mechanics

Hook: Announcement
Structure: Hook → Landing
Style: Conversational paragraphs at a steady pace.
Tone: corporate
Written for: Founders, marketers and operators

Analysis by ViralLoop — not written by the original author.

Topics

Science Food tech

Post by Moderna on X